Stochastic models for prodrug targeting. 1. Diffusion of the efflux drug

Molecular Pharmaceutics

Volumn 3, Issue 2, 2006, Pages 187-195

  Qi, Xiaohong ^a,b  

^a Shanghai Institute of Pharmaceutical Industry   (China)

^b Watson Pharmaceuticals Inc   (United States)

Author keywords

Efflux; Fokker Planck equation; Partial differential equations; Prodrug targeting; Stochastic model; Transport phenomena; Transporter

Indexed keywords

PRODRUG;

ARTICLE; DRUG ABSORPTION; DRUG DIFFUSION; DRUG TARGETING; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROBABILITY; SPATIAL ORIENTATION; STOCHASTIC MODEL; TIMED DRUG RELEASE;

BIOLOGICAL TRANSPORT; DIFFUSION; MODELS, BIOLOGICAL; PRODRUGS; STOCHASTIC PROCESSES;

EID: 33646355436     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp050089l     Document Type: Article

References (56)

1. Higuchi, T., Stella, V., Eds. Prodrugs As Novel Drug Delivery Systems; ACS Symposium Series; American Chemical Society. Washington, DC, 1975; pp 1-115.
2. Han, H. K.; Amidon, G. L. Targeted Prodrug Design to Optimize Drug Delivery. AAPS PharmSci 2000, 2, article 6.
3. Prodrug symposium; AAPS annual meeting and exposition; Nashville, TN, 2005.
4. Li, X. Z.; Nikaido, H. Efflux-based drug resistance in baceria. Drugs 2004, 64, 159-204.
5. Andersen, C. Channel-tunnels: outer membrane components of type 1 secretion systems and multidrug efflux pumps of Gram-negative bacteria. Rev. Physiol. Biochem. Pharmacol. 2003, 147, 122-65.
6. Mandkhetkorn, S.; Garnier-Suillero, A. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake. Eur. J. Pharmacol. 1998, 19, 343, 313-21.
7. Aszalos, A.; Thompson, K.; Yin, J. J.; Ross, D. D. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). Anticancer Res. 1999, 19, 1053-64.
8. Gatlik-Lanwoitowicz, E.; Anismaa, P.; Seeling, A. The rate of P-glycoprotein activation depends on the metabolic state of the cell Biochemistry 2004, 43, 14840-51.
9. Vernhet, L.; Seite, M. P.; Allain, N.; Guillouzo, A.; Fardel, O. Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J. Pharmacol Exp. Ther. 2001, 298, 234-9.
10. Zhang, J. T. Sequence requirements for membrane assembly of polytopic membrane proteins: molecular dissection of the membrane insertion process and topogenesis of the human MDR3 P-glycoprotein. Mol. Biol. Cell 1996, 7, 1709-21.
11. Seeling, A.; Macdonald, P. M., Binding of a neuropeptide, substance P, to neutral and negatively charged lipids. Biochemistry 1989, 28, 2490-6.
12. Watier, H. Variability factors in the clinical response to recombinant antibodies and IgG Fc-containing fusion proteins. Expert Opin. Biol. Ther. 2005, Suppl. 1, S29-36.
13. Ramanathan, M. An application of Ito's lemma in population pharmacokinetics and pharmacodynamics. Pharm. Res. 1999, 16, 584-6.
14. Puchalka, J.; Kierzek, A. M. Bridging the gap between stochastic and deterministic regimes in the kinetic simulations of the biochemical reaction networks. Biophys. J. 2004, 86, 1357-72.
15. Meng, T. C.; Somani, S.; Dhar, P. Modeling and simulation of biological systems with stochasticity. In Silico Biol. 2004, 4, 293-309.
16. Berg, H. C. Random Walks in Biology; Princeton University Press: New York, 1993.
17. Gardiner, C. W. Handbook of Stochastic Methods for Physics, Chemistry and The Natural Sciences; Springer: Berlin, 2001.
18. Risken, H. The Fokker-Planck Equation: Methods of Solutions and Applications; Springer: New York, 1996.
19. Frehland, E. Theory of transport noise in membrane channels with open-closed kinetics. Biophys. Struct. Mech. 1979, 5, 91-106.
20. Goychuk, I. Rate processes with non-Markovian dynamical disorder. J. Chem. Phys. 2005, 122, 164506.
21. Ramanathan, M. A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data. Drug Metab. Dispos. 1999, 27, 1479-87.
22. Dehling, H. G.; Hoffmann, A. C.; Stuut, H. W. Stochastic models for transport in fluidized bed. SIAM J. Appl. Math. 1999, 60, 337-58.
23. Dabrowski, A. R.; Dehling, H. G. Jump diffusion approximation for a Markovian transport model. In Asymptotic methods in probability and statistics; Szyszkowicz, B., Ed.; Elsevier Science, North-Holland: Amsterdam, 1998; pp 115-25.
24. Lugo, M. R.; Sharom, F. J. Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site. Biochemistry 2005, 44, 643-55.
25. Schwartz, J. W.; Blakely, R. D.; DeFelice, L. J. Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. J. Biol. Chem. 2003, 278, 9768-77.
26. Schwartz, J. W.; Novarino, G.; Piston, D. W.; DeFelice, L. J. Substrate binding stoichiometry and kinetics of the norepinephrine transporter. J. Biol. Chem. 2005, 280, 19177-84.
27. Mason, J. N.; Farmer, H.; Tomlison, I. D.; Schwartz, J. W.; Savchenko, V.; DeFelice, L. J.; Rosenthal, S. J.; Blakely, R. D. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation. J. Neurosci. Methods 2005, 143, 3.
28. Hopener, C.; Siebrasse, J. P.; Peters, R.; Kubitscheck, U.; Naber, A. High-resolution near-field optical imaging of single nuclear pore complexes under physiological conditions. Biophys. J. 2005, 88, 3681-8.
29. Matsumoto, R.; Suhara, T. In vivo evaluation of expressed protein function by PET. Nihon Shinkei Seishin Yakurigaku Zasshi 2005, 25, 137-41.
30. Wang, H.; Peskin, C. S.; Elston, T. C. A robust numerical algorithm for studying biomolecular transport processes. J. Theor. Biol. 2003, 221, 491-511.
31. Meller, A. Dynamics of polynucleotide transport through nanometer-scale pores. J. Phys. Condens. Matter. 2003, 15, R581-607.
32. Connors, T. A. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 1995, 2, 702-709.
33. Shibata, A.; Murata, S.; Ueno, S.; Liu, S.; Futaki, S.; Baba, Y. Synthetic copoly(Lys/Phe) and poly(Lys) translocate through lipid bilayer membranes. Biochim. Biophys. Acta 2003, 1616, 147-55.
34. Pajeva, K.; Wiese, M. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis). J. Med. Chem. 2002, 45, 5671-86.
35. Humphrey, M. J.; Ringrose, P. S. Peptides and related drugs: a review of their absorption, metabolism, and excretion. Drug Metab. Rev. 1986, 17, 283-310.
36. Tamai, I.; Ling, H. Y.; Timbul, S. M.; Nishikido, J.; Tsuji, A. Stereospecific absorption and degradation of cephalexin. J. Pharm. Pharmacol. 1988, 40, 320-4.
37. Sinko, P. J.; Balimane, P. V. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats. Biopharm. Drug Dispos. 1998, 19, 209-17.
38. Karki, S. B.; Ostovic, D. Assessing aggregation of peptide conjugate of doxorubicin using quasi-elastic light scattering and 600 MHz NMR. Int. J. Pharm. 2004, 277 (1-2), 181-7.
39. Gangwar, S.; Jois, S. D.; Siahaan, T. J.; Vander Velder, D. S.; Stella, V. J.; Borchardt, R. T. The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide. Pharm. Res. 1996, 13, 1657-62.
40. Mitchell, P. Microfluidics-downsizing large-scale biology. Nat. Biotechnol. 2001, 19, 717-21.
41. Reese, T. S.; Karnovsky, M. J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34 (1), 207-17.
42. He, L.; Liu, G. Q. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacol. Sin. 2002, 23 (7), 591-6.
43. Qi, X.; Ackermann, C.; Sun, D.; Liu, R.; Sheng, M.; Hou, H. The prediction of plasma and brain levels of 2,3,5,6-tetramethyplyrazine following transdermal application. AAPS PharmSci. 2002, 4 (4), E46.
44. Tsai, T. H.; Liang, C. Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis. Int. J. Pharm. 2001, 216 (1-2), 61-6.
45. Qi, X.; Ackermann, C.; Sun, D.; Sheng, M.; Hou, H. Physicochemical characterization and percutaneous delivery of 2,3,5,6-tetramethylpyrazine. Int. J. Pharm. 2003, 253 (1-2), 177-83.
46. Singer, A.; Schuss, Z. Brownian simulations and unidirectional flux in diffusion. Phys. Rev. E 2005, 71, 026115.
47. Pandey, P.; Turton, R. Movement of Different-Shaped Particles in a Pan-Coating Device Using Novel Video-Imaging Techniques. AAPS PharmSciTech 2005, 6 (2), E237-44.
48. Song, Y.; Turton, R. A contact algorithm for Tablet-Shaped Bodies in DEM. AIChE Annual Meeting, San Francisco, CA, 2003; Vol. 1, pp 892-901.
49. Proctor, S. D.; Vine, D. F.; Mamo, J. C. Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler., Thromb., Vasc. Biol. 2004, 24 (11), 2162-7.
50. Huang, H.; Zhang, J.; Jiang, H.; Wakana, S.; Poetscher, L.; Miller, M. I.; van Zijl, P. C. M.; Hillis, A. E.; Wytik, R.; Mori, S. DTI tractography based parcellation of white matter: Application to the mid-sagittal morphology of corpus callosum. NeuroImage 2005, 1, 195-205.
51. Wset, R. M.; Aykroyd, R. G.; Meng, S.; Williams, R. A. Markov chain Monte Carlo techniques and spatial-temporal modelling for medical EIT. Physiol. Meas. 2004, 25, 181-194.
52. Lakadamyali, M.; Rust, M. J.; Babcock, H. P.; Zhuang, X.; Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (16), 9280-5.
53. Brown, E. N.; Meehan, P. M.; Dempster, A. P. A stochastic differential equation model of diurnal cortisol patterns. Am. J. Physiol. Endocrinol. Metab. 2001, 280, E450-61.
54. Yeagel, P. L. The Structure of Biological Membranes, 2nd ed.; CRC: Boca Raton, 2004.
55. Siegel, R. A. Commentary to "Linear and nonlinear system approaches in pharmacokinetics. how much do they have to offer? I. General considerations". J. Pharmacokinet. Biopharm. 1988, 16, 667-72.
56. Tornoe, C. W.; Overgaard, R. V.; Agerso, H.; Nielsen, H. A.; Madsen, H.; Jonsson, E. N. Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations. Pharm. Res. 2005, 22, 1247-58.